Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-25-000908
Filing Date
2025-08-07
Accepted
2025-08-07 12:30:01
Documents
37
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bhic10q063025.htm   iXBRL 10-Q 375235
2 EXHIBIT 31.1 bhicex31-1.htm EX-31.1 12907
3 EXHIBIT 31.2 bhicex31-2.htm EX-31.2 12939
4 EXHIBIT 32.1 bhicex32-1.htm EX-32.1 5322
5 EXHIBIT 32.2 bhicex32-2.htm EX-32.2 4887
  Complete submission text file 0001185185-25-000908.txt   2040453

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bhic-20250630.xsd EX-101.SCH 13178
7 XBRL CALCULATION FILE bhic-20250630_cal.xml EX-101.CAL 18079
8 XBRL DEFINITION FILE bhic-20250630_def.xml EX-101.DEF 71784
9 XBRL LABEL FILE bhic-20250630_lab.xml EX-101.LAB 141597
10 XBRL PRESENTATION FILE bhic-20250630_pre.xml EX-101.PRE 82286
39 EXTRACTED XBRL INSTANCE DOCUMENT bhic10q063025_htm.xml XML 113868
Mailing Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115
Business Address 2722 S WEST TEMPLE SALT LAKE CITY UT 84115 801-949-0791
BioScience Health Innovations, Inc. (Filer) CIK: 0001784440 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-234487 | Film No.: 251192744
SIC: 7374 Services-Computer Processing & Data Preparation
(CF Office: 06 Technology)